brought By the Acquisition of Monsanto, Bayer problems with glyphosate into the house. Now agreed, the company with the U.S. plaintiffs in a billion-dollar comparison.

2018, the agricultural chemical and pharmaceutical group Bayer acquired the U.S. company Monsanto. Now, the company has been in legal conflict with U.S. plaintiffs agreed because of alleged cancer risk of glyphosate-containing weed killers on a comparison. The agricultural chemical and pharmaceutical group expects according to a statement from Wednesday in order to pay for the settlement of current and possible future cases 9.1 billion to 9.8 billion euros.

Bayer had brought to the glyphosate-problems with the over 60-billion-Dollar Acquisition of Monsanto into the house. There are three lost processes, and high compensation followed killers judgments because of alleged cancer risk from Weeds. Bayer fought against the previous judgments, negotiated a comparison. Analysts have estimated in advance that this could cost in the tens of billions of euros. On Monday, the Bayer group had achieved a victory in court: The company does not have to warn in California prior to glyphosate-cancer risks*.

Whether or not glyphosate is a carcinogen or not, it was not able to clarify the science to date finally. The classification of the IARC and by other researchers in opposition to Bayer numerous studies. The U.S. EPA supports the group and is holding so far, in spite of the heated debate to glyphosate because of the controversial pesticide in the case of requirement performing of intended use no health risk to humans. (dpa/tab)

*fr.de is part of the nationwide Ippen-Digital-editor.